8-K - Oncotelic Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement See Item 3.02 below, Item 3.02 Unregistered Sales of Equity Securities. On December 31, 2025, Oncotelic Therapeutics,

Material Agreement

$25.0K$1.00$1.25$1.00

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description Filed on 10.1 Form of Subscription Agreement Form 8-K on 12/09/2025 10.2 Form of Privat

Exhibits Only

Exhibits (1)

8-K